Navigation Links
InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
Date:9/30/2009

LOS ALTOS, Calif., Sept. 30 /PRNewswire/ -- InteKrin Therapeutics Inc. announced today positive results for INT131 in long term, high exposure preclinical safety studies. Data will be presented at the 45th Annual European Association for the Study of Diabetes Meeting in Vienna, Austria at 12:45 PM Thursday, October 1, 2009 by InteKrin Therapeutics' Chief Operating Officer, Linda Higgins, PhD, in a presentation "Chronic Cardiovascular Safety of INT131 Besylate, a Selective PPAR-gamma Modulator (SPPARM) in Rodents and Monkeys is Differentiated from TZD Full Agonists."

"Typical cardiovascular effects noted with PPAR-gamma full agonists in preclinical and clinical studies, such as weight gain, fluid retention, cardiac hypertrophy, and premature death were not observed in the 2-year studies in rats and mice, or in a 1-year study in cynomolgus monkeys even at the highest doses tested, which provided very high exposure multiples of the clinical exposure at efficacious doses," said Dr. Higgins. "Results are consistent with in vitro and in vivo studies and with clinical data demonstrating a SPPARM profile of INT131 having unique PPAR-gamma activating properties with minimal cardiovascular side effects."

"Chronic nonclinical safety studies of PPAR-gamma ligands have been highly predictive of clinical experience," noted Jeri El Hage, PhD, an expert in PPAR toxicology who served over 18 years in the Center for Drug Evaluation and Research (CDER) at the FDA. "INT131 displayed an unprecedented preclinical safety profile with no cardiac safety signals at exposure multiples far greater than other PPAR agonists tested to date."

The high cardiovascular safety margin validates the design of INT131 to minimize the safety and tolerability issues associated with full agonist PPAR-gamma agents while retaining the clinically proved anti-diabetic properties of PPAR-gamma. In addition, the 2-year rodent studies showed no evidence of
'/>"/>

SOURCE InteKrin Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
2. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
3. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Ohio , Aug. 31, 2015 ... applications, has acquired MACTek Corporation, a leading provider ... of Pepperl+Fuchs, strategy to further extend its integrated ... WirelessHART market.    "We are pleased ... our existing portfolio," said Jim Bolin , ...
(Date:8/31/2015)... 2015 With increasing clinical applications, the ... rise in active partnerships. The primary reason for ... quantitate CD4 cell markers in human immunodeficiency virus ... New analysis from Frost ... Market ( http://www.frost.com/nf0e ), finds the market earned ...
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs professionals ... where regulations are often strict and legislation is ... a demand for professionals who have a deep ... across a product lifecycle and demonstrate its use ... University of California, Irvine Extension , in partnership ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3
... , , ...  (AIM: CRW.L), the market leader in automated revenue integrity ... new product and its first customer. , Supplies ... manage and optimize reimbursement for chargeable supplies. It does this ...
... , , JERUSALEM , ... privately held biopharma company, announced today that it has granted Novartis ... the Company,s Transient Permeability Enhancer (TPE) technology for use with certain ... Novartis. In a separate but related agreement, the MPM Bio ...
Cached Medicine Technology:Craneware's New Product Reduces Supply Chain Revenue Leakage 2Craneware's New Product Reduces Supply Chain Revenue Leakage 3Craneware's New Product Reduces Supply Chain Revenue Leakage 4Chiasma Grants Option to License Transient Permeability Enhancer (TPE) Technology for Small Molecule Products 2Chiasma Grants Option to License Transient Permeability Enhancer (TPE) Technology for Small Molecule Products 3
(Date:9/1/2015)... ... September 01, 2015 , ... Suzanne Bakken, PhD, RN, FAAN, ... Institute of Medicine (IOM) of the National Academies. , She is the Alumni ... Nursing. A member of the Institute of Medicine since 2006, Bakken also currently ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... more than 1,500 investor-families have received permanent green cards (I-829 petition approval) from ... The I-829 petition is the final step of the EB-5 visa process for ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland Street, ... will be attending from across the country. All specialties will be represented. Attendees ...
(Date:9/1/2015)... ... 01, 2015 , ... Situations requiring fast, easy-to-understand business and ... convenient time for everyone involved. These occasions highlight the value of a professional ... has real people available to handle any translation assignment at any time ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... is, how to access caregivers and what to look for and expect when ... information. , Founded in 2006 in Canoga Park, CA by CEO, Richard Weatherman ...
Breaking Medicine News(10 mins):Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2
... debate over comprehensive healthcare reform now in full swing, ... a new national broadcast advertising campaign touting the importance ... prescription drug benefit (Part D). , ... coverage and choice for seniors and disabled Americans, according ...
... the availability of the report " A Growing Body ... featuring SenoRx, Inc. (NasdaqGM: SENO) and of interest to ... EVVV), AngioDynamics Inc. (NasdaqGS: ANGO), Thoratec Corp. (NasdaqGS: THOR) ... read the article " A Growing Body of Evidence ...
... Physicians Practice and the Pocono Medical Center have joined ... more time to devote to patient care. This new ... in and around Monroe County, Pennsylvania better handle the ... Through this new alliance, Pocono Medical Center will use ...
... During Pregnancy; Infants Should Undergo Oral Health Assessment by ... The American Academy of Pediatric Dentistry (AAPD), the ... health guidelines for expectant mothers and infants following its ... for all pregnant women to receive counseling and oral ...
... Top Vacation Spots Place Visitors at Risk for Increased UV ... As travelers and their families head off to their favorite ... risk for increased exposure to the sun,s dangerous ultraviolet (UV) ... like beaches and islands in warmer climates, are spots that ...
... Development , , WASHINGTON and CHADDS FORD, Pa., June 10 ... saw two or more doctors before the condition was diagnosed, and ... their medicine, according to results of a survey released today. , ... who had been diagnosed with and treated for low testosterone, were ...
Cached Medicine News:Health News:PhRMA Launches Campaign to Raise Awareness of Success of Medicare Prescription Drug Benefit 2Health News:SmallCapSentinel.com Releases Report for Investors of Medical Device Companies SENO, STXS, EVVV, ANGO, THOR, and CPTS 2Health News:Physicians Practice and Pocono Medical Center to Improve Patient Care in Monroe County, Pennsylvania 2Health News:Physicians Practice and Pocono Medical Center to Improve Patient Care in Monroe County, Pennsylvania 3Health News:Physicians Practice and Pocono Medical Center to Improve Patient Care in Monroe County, Pennsylvania 4Health News:American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 2Health News:American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 3Health News:American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 4Health News:Summer Travel Destinations are Heavy on Fun - and Sun 2Health News:Summer Travel Destinations are Heavy on Fun - and Sun 3Health News:Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options 2Health News:Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options 3Health News:Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options 4Health News:Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options 5Health News:Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options 6
... next generation system for ... the power of automation ... laboratory. As many as ... loaded and analyzed in ...
The NIAGARA Thermal Retention System (TRS) maintains the temperature of prewarmed irrigation fluid continuously as it is delivered through the Corson®, Surgiflex® WAVE™, or Surgiflex D...
Simple, Effective Laparoscopic Irrigation Pumps from the Market Leader...
Stryker Endoscopy has combined a standardized pressurizing system with an advanced hand piece design that is lightweight and compact in order to streamline laparoscopic procedures....
Medicine Products: